Harmony Biosciences Holdings, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2020 to Q3 2024.
  • Harmony Biosciences Holdings, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $5.96M, a 0.02% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $23.8M, a 0.01% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Amortization of Intangible Assets for 2023 was $23.8M, a 3.83% increase from 2022.
  • Harmony Biosciences Holdings, Inc. annual Amortization of Intangible Assets for 2022 was $23M, a 24.7% increase from 2021.
  • Harmony Biosciences Holdings, Inc. annual Amortization of Intangible Assets for 2021 was $18.4M, a 87.2% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $23.8M $5.96M -$1K -0.02% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $23.8M $5.96M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $23.8M $5.96M $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $23.8M $5.96M -$1K -0.02% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $23.8M $5.96M +$1K +0.02% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $23.8M $5.96M $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $23.8M $5.96M +$879K +17.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $23M $5.96M +$1.32M +28.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $21.6M $5.96M +$1.39M +30.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $20.3M $5.96M +$1.33M +28.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $18.9M $5.08M +$503K +11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $18.4M $4.64M +$360K +8.41% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $18.1M $4.57M +$2.71M +145% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $15.4M $4.63M +$2.72M +143% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $12.6M $4.58M +$2.79M +156% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $9.84M $4.28M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $1.87M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.91M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $1.79M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.